scispace - formally typeset
Open Access

Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis

Reads0
Chats0
TLDR
Whether more progress would be achieved in DSM-V by abandoning the familiar categorical system and instead moving to a dimensional system which rates both developmental impairment and symptom factor scores is discussed.
Abstract
The diagnostic criteria for schizophrenia in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV1) are based on the premise that it is a discrete illness entity, in particular, distinct from the affective psychoses. This assumption has persisted for more than a century, even though patients with a diagnosis of schizophrenia show a wide diversity of symptoms and outcomes, and no biological or psychological feature has been found to be pathognomonic of the disorder. However, there has been sustained, and indeed growing, criticism of the concept. For example, writing about the diagnosis of schizophrenia more than a decade ago,2 one of Britain's most sophisticated nosological experts, Ian Brockington, enjoined “It is important to loosen the grip which the concept of ‘schizophrenia’ has on the minds of psychiatrists. Schizophrenia is an idea whose very essence is equivocal, a nosological category without natural boundaries, a barren hypothesis. Such a blurred concept is ‘not a valid object of scientific enquiry’.”3 Should Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition(DSM-V), persist with the neo-Kraepelinian concept of schizophrenia with all its defects, or should it deconstruct psychosis into its component dimensions? In this article, we will address the question by considering 2 main themes, firstly, the role of culture and ethnicity in the diagnosis of psychosis, and secondly, a life course approach to understanding psychosis. We will then discuss whether more progress would be achieved in DSM-V by abandoning the familiar categorical system and instead moving to a dimensional system which rates both developmental impairment and symptom factor scores. However, we will begin by briefly reviewing the recent history of the classification of the psychoses.

read more

Citations
More filters
Journal ArticleDOI

The Dopamine Hypothesis of Schizophrenia: Version III—The Final Common Pathway

TL;DR: The dopamine hypothesis of schizophrenia-version III is synthesized into a comprehensive framework that links risk factors, including pregnancy and obstetric complications, stress and trauma, drug use, and genes, to increased presynaptic striatal dopaminergic function.
Journal ArticleDOI

Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort.

TL;DR: The results indicate that children who have psychotic symptoms can be recruited for neuroscience research to determine the pathogenesis of schizophrenia and indicate that psychotic symptoms in childhood are often a marker of an impaired developmental process and should be actively assessed.
Journal ArticleDOI

The slow death of the concept of schizophrenia and the painful birth of the psychosis spectrum

TL;DR: It is tentatively concluded that with the advent of broad spectrum phenotypes covering autism and addiction in DSM5, the prospect for introducing a psychosis spectrum disorder – and modernizing psychiatry – appears to be within reach.
Journal ArticleDOI

The evolution of drug development in schizophrenia: past issues and future opportunities.

TL;DR: Success in drug discovery for cognition and negative symptom pathologies may bring forth issues in ethics as the potential for enhancing normal function is explored, raising the possibility of very early intervention and secondary prevention.
References
More filters
Journal ArticleDOI

The Dopamine Hypothesis of Schizophrenia: Version III—The Final Common Pathway

TL;DR: The dopamine hypothesis of schizophrenia-version III is synthesized into a comprehensive framework that links risk factors, including pregnancy and obstetric complications, stress and trauma, drug use, and genes, to increased presynaptic striatal dopaminergic function.
Journal ArticleDOI

Negative v positive schizophrenia. Definition and validation.

TL;DR: Criteria for dividing the schizophrenic syndrome into three subtypes was developed: positive, negative, and mixed schizophrenia, and significant differences were noted using external validators such as premorbid adjustment, indices of cognitive dysfunction, ventricular brain ratio, and course in hospital.
Journal ArticleDOI

Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia

TL;DR: It was shown by follow-up and family studies that poor prognosis cases can be validly separated clinically from good prediction cases, and the authors conclude that good prognosis "schizophrenia" is not mild schizophrenia, but a different illness.
Journal ArticleDOI

Schizophrenia and migration: a meta-analysis and review.

TL;DR: Findings of previous studies implicating migration as a risk factor for the development of schizophrenia and a quantitative index of the associated effect size are synthesized to suggest a role for psychosocial adversity in the etiology of schizophrenia.
Related Papers (5)